HSBC Holdings’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-69,728
| Closed | -$641K | – | 3060 |
|
|
2026
Q1 | $641K | Sell |
69,728
-577
| -0.8% | -$6.33K | ﹤0.01% | 2097 |
|
|
2025
Q4 | $879K | Buy |
+70,305
| New | +$935K | ﹤0.01% | 2011 |
|
|
2025
Q2 | – | Sell |
-40,323
| Closed | -$887K | – | 3117 |
|
|
2025
Q1 | $887K | Buy |
40,323
+30,331
| +304% | +$713K | ﹤0.01% | 1806 |
|
|
2024
Q4 | $227K | Sell |
9,992
-617
| -6% | -$13.5K | ﹤0.01% | 2648 |
|
|
2024
Q3 | $191K | Buy |
+10,609
| New | +$246K | ﹤0.01% | 2633 |
|
|
2023
Q4 | – | Sell |
-19,801
| Closed | -$759K | – | 2811 |
|
|
2023
Q3 | $759K | Sell |
19,801
-20,838
| -51% | -$877K | ﹤0.01% | 1813 |
|
|
2023
Q2 | $1.68M | Buy |
40,639
+10,995
| +37% | +$529K | ﹤0.01% | 1518 |
|
|
2023
Q1 | $1.69M | Buy |
+29,644
| New | +$1.67M | ﹤0.01% | 1586 |
|
|
2022
Q4 | – | Sell |
-97,460
| Closed | -$4.22M | – | 3097 |
|
|
2022
Q3 | $4.22M | Buy |
97,460
+36,321
| +59% | +$1.86M | 0.01% | 1248 |
|
|
2022
Q2 | $3.33M | Buy |
61,139
+47,674
| +354% | +$2.86M | ﹤0.01% | 1353 |
|
|
2022
Q1 | $881K | Buy |
13,465
+4,131
| +44% | +$272K | ﹤0.01% | 2034 |
|
|
2021
Q4 | $629K | Sell |
9,334
-203
| -2% | -$13.7K | ﹤0.01% | 2314 |
|
|
2021
Q3 | $659K | Sell |
9,537
-6,625
| -41% | -$468K | ﹤0.01% | 2093 |
|
|
2021
Q2 | $1.1M | Buy |
16,162
+9,225
| +133% | +$652K | ﹤0.01% | 1719 |
|
|
2021
Q1 | $480K | Sell |
6,937
-2,069
| -23% | -$140K | ﹤0.01% | 1990 |
|
|
2020
Q4 | $585K | Sell |
9,006
-1,880
| -17% | -$101K | ﹤0.01% | 2078 |
|
|
2020
Q3 | $518K | Buy |
10,886
+2,448
| +29% | +$116K | ﹤0.01% | 1920 |
|
|
2020
Q2 | $397K | Sell |
8,438
-6,428
| -43% | -$316K | ﹤0.01% | 1982 |
|
|
2020
Q1 | $656K | Buy |
+14,866
| New | +$780K | ﹤0.01% | 1644 |
|
|
2019
Q2 | – | Sell |
-7,879
| Closed | -$439K | – | 2760 |
|
|
2019
Q1 | $439K | Buy |
+7,879
| New | +$401K | ﹤0.01% | 2170 |
|
|
2018
Q4 | – | Sell |
-4,956
| Closed | -$327K | – | 2648 |
|
|
2018
Q3 | $327K | Sell |
4,956
-17,194
| -78% | -$1.07M | ﹤0.01% | 2195 |
|
|
2018
Q2 | $1.42M | Buy |
22,150
+17,913
| +423% | +$1.11M | ﹤0.01% | 1626 |
|
|
2018
Q1 | $235K | Buy |
+4,237
| New | +$222K | ﹤0.01% | 2322 |
|
|
2017
Q1 | – | Sell |
-13,662
| Closed | -$586K | – | 2329 |
|
|
2016
Q4 | $586K | Buy |
+13,662
| New | +$555K | ﹤0.01% | 1715 |
|
Other funds holding IART
RCMNY
PCMI
HSBC Holdings's IART Position: Q2 2026 in Review
HSBC Holdings sold out of Integra LifeSciences (IART) in Q2 2026, closing a stake of 69,728 shares — an estimated $641K sold.
HSBC Holdings first reported a position in IART in Q4 2016 and held it in 24 quarters. The position peaked at $4.22M in Q3 2022. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.
- HSBC Holdings reported no remaining Integra LifeSciences position as of Q2 2026 after selling out during the quarter.
- HSBC Holdings sold 69,728 Integra LifeSciences shares in Q2 2026, an estimated $641K.
- HSBC Holdings first reported a position in Integra LifeSciences in Q4 2016 and held it in 24 quarters.
- HSBC Holdings's Integra LifeSciences position peaked at $4.22M in Q3 2022.
- 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.
Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.